M. Babul Islam

Prof. Dr. M. Babul Islam

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
MMMohammad Ali Moni
Mohammad Ali Moni
Hunayan Kabir RanaHunayan Kabir Rana
Hunayan Kabir Rana
MIM. Babul Islam
M. Babul Islam
Mohammad Boshir AhmedMohammad Boshir Ahmed
Mohammad Boshir Ahmed
HXHaoming Xu
Haoming Xu
JQJulian Quinn
Julian Quinn

29 November 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMohammad Ali Moni
Mohammad Ali Moni
Hunayan Kabir RanaHunayan Kabir Rana
Hunayan Kabir Rana
MIM. Babul Islam
M. Babul Islam
Mohammad Boshir AhmedMohammad Boshir Ahmed
Mohammad Boshir Ahmed
PLPietro Lio'
Pietro Lio'
JQJulian M.W. Quinn
Julian M.W. Quinn
Identification of genes whose regulation of expression is similar in both brain and blood cells could enable monitoring of significant neurological traits and disorders by analysis of blood samples. We thus employed transcriptional analysis of pathologically affected tissues, using agnostic approaches to identify overlapping gene functions and integrating this transcriptomic information with expression quantitative trait loci (eQTL) data. Here, we estimate the correlation of genetic expression in the top-associated cis-eQTLs of brain tissue and blood cells in Parkinson’s (PD). We introduced quantitative frameworks to reveal the complex relationship of various biasing genetic factors in PD, a neurodegenerative disease. We examined gene expression microarray and RNA-Seq datasets from human brain and blood tissues from PD-affected and control individuals. Differentially expressed genes (DEG) were identified for both brain and blood cells to determine common DEG overlaps. Based on neighborhood-based benchmarking and multilayer network topology aproaches we then developed genetic associations of factors with PD. Overlapping DEG sets underwent gene enrichment using pathway analysis and gene ontology methods, which identified candidate common genes and pathways. We identified 12 significantly dysregulated genes shared by brain and blood cells, which were validated using dbGaP (gene SNP-disease linkage) database for gold-standard benchmarking of their significance in disease processes. Ontological and pathway analyses identified significant gene ontology and molecular pathways that indicate PD progression. In sum, we found possible novel links between pathological processes in brain and blood cells by examining cell path-way commonalities, corroborating these associations using well validated datasets. This demonstrates that for brain-related pathologies combining gene expression analysis and blood cell cis-eQTL is a potentially powerful analytical approach. Thus, our methodologies facilitate data-driven approaches that can advance knowledge of disease mechanisms and may enable prediction of neurological dysfunction using blood cell transcript profiling.

29 November 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
UCUtpala Nanda Chowdhury
Utpala Nanda Chowdhury
SAShamim Ahmad
Shamim Ahmad
MIM. Babul Islam
M. Babul Islam
FHFazlul Huq
Fazlul Huq
JQJulian M.W. Quinn
Julian M.W. Quinn
MMMohammad Ali Moni
Mohammad Ali Moni
Motivation: Alzheimer’s disease (AD) is currently incurable and the causative risk factors are still poorly understood, which impedes development of effective prevention and treatment strategies. We propose a network-based quantitative framework to reveal details of the complex interaction between the various genetic contributors to AD susceptibility. We analyzed gene expression microarray data from tissues affected by AD, advanced ageing, high alcohol consumption, type II diabetes, high body fat, high dietary fat, obesity, high dietary red meat intake, sedentary lifestyle, smoking, and control datasets. We developed genetic associations and diseasome networks for these factors and AD using the neighborhood-based benchmarking and multilayer network topology approaches. Results: The study identified 484 genes differentially expressed between AD and controls. Among these, 27 genes showed elevated expression both in individuals in AD and in smoker datasets; similarly 21 were observed in AD and type II diabetes datasets and 12 for AD and sedentary lifestyle datsets. However, AD shared less than ten such elevated expression genes with other factors examined. 3 genes, namely HLA-DRB4, IGH and IGHA2 showed increased expression among the AD, type II diabetes and alcohol consumption datasets; 2 genes, IGHD and IGHG1, were commonly up-regulated among the AD, type II diabetes, alcohol consumption and sedentary lifestyle datasets. Protein-protein interaction networks identified 10 hub genes: CREBBP, PRKCB, ITGB1, GAD1, GNB5, PPP3CA, CABP1, SMARCA4, SNAP25 and GRIA1. Ontological and pathway analyses genes, including Online Mendelian Inheritance in Man (OMIM) and dbGaP databases were used for gold benchmark gene-disease associations to validate the significance of these putative target genes of AD progression. Conclusion: Our network-based methodologies have uncovered molecular pathways that may influence AD development, suggesting novel mechanisms that contribute to AD risk and which may form the basis of new therapeutic and diagnostic approaches. Contact: mohammad.moni@sydney.edu.au

30 November 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
NSNajmus Sakib
Najmus Sakib
UCUtpala Nanda Chowdhury
Utpala Nanda Chowdhury
MIM. Babul Islam
M. Babul Islam
JQJulian Quinn
Julian Quinn
MMMohammad Ali Moni
Mohammad Ali Moni
Actual causes of Parkinsons disease (PD) are still unknown. In any case, a better comprehension of genetic and ecological influences to the PD and their interaction will assist physicians and patients to evaluate individual hazard for the PD, and definitely, there will be a possibility to find a way to reduce the progression of the PD. We introduced quantitative frameworks to reveal the complex relationship of various biasing genetic factors for the PD. In this study, we analyzed gene expression microarray data from the PD, ageing (AG), severe alcohol consumption (AC), type II diabetes (T2D), high body fat (HBF), hypercholesterolemia (HC), high dietary fat (HDF), red meat dietary (RMD), sedentary lifestyle (SL), smoking (SM), and control datasets. We have developed genetic associations of various factors with the PD based on the neighborhood-based benchmarking and multilayer network topology. We identified 1343 significantly dysregulated genes in the PD patients compared to the healthy control, where we have 779 genes down regulated and 544 genes up regulated. 69 genes were highly expressed in both for the PD and alcohol consumption whereas the number of shared genes for the PD and the type II diabetes is 51. However, the PD shared 45, 43 and 42 significantly expressed genes with the ageing, high dietary fat and high body fat respectively. The PD shared less than 40 significant transcripts with other factors. Ontological and pathway analyses have identified significant gene ontology and molecular pathways that enhance our understanding of the fundamental molecular procedure of the PD progression. Therapeutic targets of the PD could be developed using these identified target genes, ontologies and pathways. Our formulated methodologies demonstrate a network-based approach to understand the disease mechanism and the causative reason of the PD, and the identification for therapeutic targets of the PD.